11 results on '"Marwan Yared"'
Search Results
2. Primary cutaneous Hodgkin-like polymorphic post-transplant lymphoproliferative disorder
- Author
-
Viraat Patel, Heather S. Barker, Alejandro Restrepo, Carly Dunn, Harry Dao, A. Hafeez Diwan, Marwan Yared, Harrison P. Nguyen, and Tarek Elghetany
- Subjects
medicine.medical_specialty ,Pathology ,Histology ,Hematology ,business.industry ,medicine.medical_treatment ,Polymorphic PTLD ,Immunosuppression ,Dermatology ,medicine.disease ,Post-transplant lymphoproliferative disorder ,Pathology and Forensic Medicine ,Lymphoma ,030207 dermatology & venereal diseases ,03 medical and health sciences ,surgical procedures, operative ,0302 clinical medicine ,hemic and lymphatic diseases ,030220 oncology & carcinogenesis ,Internal medicine ,medicine ,Dermatopathology ,Hematopathology ,Complication ,business - Abstract
Post-transplant lymphoproliferative disorder (PTLD) is an uncommon complication after solid-organ transplants and hematopoietic stem cell transplants. Isolated involvement of the skin without systemic involvement in PTLD is extremely rare. Primary cutaneous PTLD is generally categorized as either cutaneous T-cell lymphoma or cutaneous B-cell lymphoma, with variable Epstein-Barr virus (EBV) positivity. Herein, we describe an exceedingly uncommon case of a primary cutaneous Hodgkin-like polymorphic PTLD. A man in his 60s, with a history of kidney transplant, presented with a 5-week history of two indurated plaques. Clinical, histologic and immunohistochemical findings were consistent with primary cutaneous Hodgkin-like polymorphic PTLD. Reduction in immunosuppression led to resolution of his lesions. This case highlights a rare case of primary cutaneous Hodgkin-like PTLD and increases awareness of this uncommon post-transplant complication. It also underscores the importance of collaboration between dermatology, hematology, dermatopathology and hematopathology in order to diagnose challenging cases.
- Published
- 2019
3. Attitudes and Beliefs of Pathology Residents Regarding the Subspecialty of Clinical Chemistry: Results of a Survey
- Author
-
Suzanne Zein-Eldin Powell, Marwan Yared, Mehran Haidari, C. Bruce Alexander, and Juan P. Olano
- Subjects
Pathology ,medicine.medical_specialty ,Attitude of Health Personnel ,MEDLINE ,Subspecialty ,Pathology and Forensic Medicine ,03 medical and health sciences ,0302 clinical medicine ,Surveys and Questionnaires ,medicine ,Humans ,Chemistry (relationship) ,Medical education ,business.industry ,Internship and Residency ,General Medicine ,030224 pathology ,Pathologists ,Medical Laboratory Technology ,Education, Medical, Graduate ,Chemistry, Clinical ,030220 oncology & carcinogenesis ,Family medicine ,Clinical education ,business - Abstract
Context.—Previous studies suggest that training in pathology residency programs does not adequately prepare pathology residents to become competent in clinical chemistry.Objectives.—To define the beliefs of pathology residents in the United States regarding their preparation for practicing clinical chemistry in their career, their attitude toward the discipline, and the attractiveness of clinical chemistry as a career.Design.—The residents of all pathology residency programs in the United States were given the opportunity to participate in an online survey.Results.—Three hundred thirty-six pathology residents responded to the survey. Analysis of the survey results indicates that pathology residents are more likely to believe that their income may be lower if they select a career that has a clinical chemistry focus and that their faculty do not value clinical chemistry as much as the anatomic pathology part of the residency. Residents also report that clinical chemistry is not as enjoyable as anatomic pathology rotations during residency or preferable as a sole career path. A large proportion of residents also believe that they will be slightly prepared or not prepared to practice clinical chemistry by the end of their residency and that they do not have enough background and/or time to learn clinical chemistry during their residency programs to be able to practice this specialty effectively post graduation.Conclusions.—Our survey results suggest that many pathology residents do not have a positive attitude toward clinical chemistry and do not experience a supportive learning environment with an expectation that they will become competent in clinical chemistry with a residency alone.
- Published
- 2016
4. Statistical Literacy Among Academic Pathologists: A Survey Study to Gauge Knowledge of Frequently Used Statistical Tests Among Trainees and Faculty
- Author
-
Deborah J. Chute, Jorie M. Colbert-Getz, Kristie L. White, Brandon S. Walker, Robert L. Schmidt, Andrew Wilson, Marwan Yared, Kristi J. Smock, Douglas C. Miller, Ann Sutton, Daniel S. James, Eva M. Wojcik, Danny A. Milner, Julie Katz Karp, Adolfo Firpo-Betancourt, and Rachel E. Factor
- Subjects
media_common.quotation_subject ,Statistical literacy ,Biostatistics ,Laboratory testing ,Original research ,Literacy ,Pathology and Forensic Medicine ,Terminology ,03 medical and health sciences ,0302 clinical medicine ,Gauge (instrument) ,Surveys and Questionnaires ,Medicine ,Humans ,030212 general & internal medicine ,Statistical hypothesis testing ,media_common ,Medical education ,business.industry ,Internship and Residency ,Survey research ,General Medicine ,Pathologists ,Medical Laboratory Technology ,030220 oncology & carcinogenesis ,business ,Comprehension - Abstract
Context.—Statistical literacy can be defined as understanding the statistical tests and terminology needed for the design, analysis, and conclusions of original research or laboratory testing. Little is known about the statistical literacy of clinical or anatomic pathologists. Objective.—To determine the statistical methods most commonly used in pathology studies from the literature and to assess familiarity and knowledge level of these statistical tests by pathology residents and practicing pathologists. Design.—The most frequently used statistical methods were determined by a review of 1100 research articles published in 11 pathology journals during 2015. Familiarity with statistical methods was determined by a survey of pathology trainees and practicing pathologists at 9 academic institutions in which pathologists were asked to rate their knowledge of the methods identified by the focused review of the literature. Results.—We identified 18 statistical tests that appear frequently in published pathology studies. On average, pathologists reported a knowledge level between “no knowledge” and “basic knowledge” of most statistical tests. Knowledge of tests was higher for more frequently used tests. Greater statistical knowledge was associated with a focus on clinical pathology versus anatomic pathology, having had a statistics course, having an advanced degree other than an MD degree, and publishing research. Statistical knowledge was not associated with length of pathology practice. Conclusions.—An audit of pathology literature reveals that knowledge of about 12 statistical tests would be sufficient to provide statistical literacy for pathologists. On average, most pathologists report they can interpret commonly used tests but are unable to perform them. Most pathologists indicated that they would benefit from additional statistical training.
- Published
- 2016
5. Plasma Cell Neoplasms : Pathogenesis, Diagnosis and Laboratory Evaluation
- Author
-
Robert B. Lorsbach, Marwan Yared, Robert B. Lorsbach, and Marwan Yared
- Subjects
- Pathology, Medicine
- Abstract
This book provides an overview of our current understanding of the pathogenesis of the plasma cell neoplasms and comprehensively updates the reader on the laboratory techniques used in the diagnosis and prognostication of these malignancies as well as for monitoring response to therapy. Plasma Cell Neoplasms: Pathogenesis, Diagnosis and Laboratory Evaluation will be of great value to those medical professionals directly involved in the evaluation and diagnosis of clinical materials from patients with plasma cell neoplasms, including surgical pathologists, hematopathologists, and clinical pathologists.
- Published
- 2016
6. Plasma Cell Neoplasms
- Author
-
Marwan Yared and Robert B. Lorsbach
- Subjects
Pathology ,medicine.medical_specialty ,Chemistry ,medicine ,Plasma cell neoplasm - Published
- 2016
7. Introduction
- Author
-
Marwan Yared and Robert B. Lorsbach
- Published
- 2016
8. An animal model for hemolytic disease of the fetus or newborn in New Zealand White and New Zealand Red rabbits: Newborn effects
- Author
-
Karen Dorman, L. Scott Rodkey, Linda Hudon, Annelie Graham, Marwan Yared, Kenneth J. Moise, and George R. Saade
- Subjects
Hemolytic anemia ,Isoantigens ,Erythrocytes ,Erythroblastosis, Fetal ,Andrology ,Hemoglobins ,New Zealand white rabbit ,Hemolytic disease of the newborn (ABO) ,medicine ,Animals ,Humans ,Blood type ,Fetus ,biology ,business.industry ,Infant, Newborn ,Obstetrics and Gynecology ,medicine.disease ,biology.organism_classification ,Blood Cell Count ,Disease Models, Animal ,Red blood cell ,medicine.anatomical_structure ,Animals, Newborn ,Blood Group Incompatibility ,Immunology ,Gestation ,Rabbits ,Hemoglobin ,business - Abstract
Our purpose was to study the neonatal effects of red blood cell alloimmunization in a rabbit model.Eighteen does were alloimmunized to incompatible red blood cells. Does were bred twice, once with a homozygous buck of incompatible blood type and once with a homozygous buck of compatible blood type. Fetal blood sampling was undertaken on day 27 of gestation (term 28 to 31 days). Does were delivered on day 30 and the neonatal pups were anesthetized. Direct cardiac samplings were performed for hemoglobin, reticulocyte count, and direct Coombs' test. Hepatic, splenic, and renal wet weights were measured.Twenty-two pregnancies (12 compatible and 10 incompatible) were studied. Neonatal hemoglobin was higher in the compatible litters (11.1 gm/dL [7.7 to 12.6 gm/dL] vs 4.9 gm/dL [2.1 to 9.1 gm/dL], P.001), whereas no difference could be detected between the respective reticulocyte counts (34.0/100 red blood cells [27.3 to 36.1/100 red blood cells] vs 32.6/100 red blood cells [26.8 to 43.5/100 red blood cells], P =.55). The direct Coombs' assay was negative in 23 pups from 8 compatible litters and false positive (weakly positive result) in 2 pups of a ninth compatible litter. The Coombs' assay was positive in all 22 incompatible pups tested. Hepatosplenomegaly was noted in affected pups but not in controls.A disease analogous to human hemolytic disease of the newborn can be induced in the rabbit neonate.
- Published
- 1998
9. A prognostic model for survival in chronic lymphocytic leukaemia based on p53 expression
- Author
-
Francis J, Giles, B Nebiyou, Bekele, Susan, O'Brien, Jorge E, Cortes, Srdan, Verstovsek, Maria, Balerdi, Marwan, Yared, Xian, Zhou, Hagop M, Kantarjian, Michael J, Keating, Peter, Thall, and Maher, Albitar
- Subjects
Adult ,Aged, 80 and over ,Multivariate Analysis ,Humans ,Reproducibility of Results ,Middle Aged ,Tumor Suppressor Protein p53 ,Prognosis ,Immunohistochemistry ,Leukemia, Lymphocytic, Chronic, B-Cell ,Survival Analysis ,Aged - Abstract
As the abnormal expression of p53 protein is prognostically significant in some human cancers, its significance in patients with B-cell chronic lymphocytic leukaemia (CLL) was assessed. Two investigators evaluated the percentage of bone marrow mononuclear cells that stained for p53, using biopsies stained with anti-p53 monoclonal antibody (DO-7), and graded the degree of staining (0, +, ++, +++). Samples from a cohort of 90 patients with CLL were studied (median age 60 years, range 30-89 years; 57 patients were (63%) previously untreated, 22 patients (24%) had received one or two prior regimens, 11 patients had received (12%) three to seven regimens. The overall percentage of cells positive for p53 staining was a median of 43 (range 1-88). No investigator effect was detected either in overall percentage cells rated p53 positive or on the degree of staining (Pearson's correlation coefficient 0.980, P-value0.001). A Cox proportional hazards model showed that the percentage of ++ and +++ p53-positive cells correlated with various prognostic factors in CLL (P0.0001). A multivariate model incorporating prior therapy, Rai stage, beta2 microglobulin (beta2M) and p53 expression showed that only the percentage of p53-positive cells and beta2M were predictive of survival, and enabled the development of a highly predictive model of survival based on these two parameters.
- Published
- 2003
10. Change in estimated cerebral perfusion pressure after treatment with nimodipine or magnesium sulfate in patients with preeclampsia
- Author
-
J.Alan Herd, George R. Saade, Henry Nisell, Marwan Yared, Michael A. Belfort, Michael A. Varner, and Charlotta Grunewald
- Subjects
Adult ,Vasodilator Agents ,Hemodynamics ,Blood Pressure ,Preeclampsia ,Magnesium Sulfate ,Pre-Eclampsia ,Pregnancy ,medicine.artery ,medicine ,Humans ,Cerebral perfusion pressure ,Nimodipine ,Ultrasonography ,Eclampsia ,business.industry ,Obstetrics and Gynecology ,Cerebral Arteries ,medicine.disease ,Calcium Channel Blockers ,Blood pressure ,Anesthesia ,Middle cerebral artery ,Female ,business ,Perfusion ,Blood Flow Velocity ,medicine.drug - Abstract
Objective: Data are accumulating to suggest that cerebral perfusion pressure may be either abnormally high or low in preeclampsia and eclampsia. Little is known of the cerebral perfusion pressure effects of magnesium sulfate or nimodipine. Our objective in this study was to compare the change in cerebral perfusion pressure in patients with severe preeclampsia randomly selected to receive nimodipine or magnesium sulfate. Study Design: Patients with severe preeclampsia were randomly selected to receive magnesium sulfate (6 g bolus and 2 g/hr intravenous infusion) or nimodipine (60 mg taken orally every 4 hours). Transcranial Doppler ultrasonography was used to measure flow velocities in the right and left middle cerebral arteries, and the results were averaged. Measurements were obtained before treatment (baseline) and 30 minutes after the magnesium sulfate bolus was completely infused or 30 minutes after the nimodipine was ingested. Studies were performed before any other intervention. The person performing the ultrasonography was unaware of the patient's group assignment. Estimated cerebral perfusion pressure was calculated with the following formula: Estimated cerebral perfusion pressure=Velocity mean × [(Blood pressure mean – Blood pressure diastolic )/(Velocity mean – Velocity diastolic )]. The difference between estimated cerebral perfusion pressure at baseline and after treatment was compared between the 2 groups by means of the Mann-Whitney rank sum test. Results: Nine patients were randomly selected to receive nimodipine and 12 to receive magnesium sulfate. Patient demographics and severity of condition were not significantly different between the 2 groups. The change in estimated cerebral perfusion pressure was significantly different between the groups. Estimated cerebral pefusion pressure increased after nimodipine use and decreased after magnesium sulfate use. Conclusion: Shortly after administration to patients with severe preeclampsia, nimodipine resulted in increased cerebral perfusion pressure in comparison with magnesium sulfate. (Am J Obstet Gynecol 1999;181:402-7.)
- Published
- 1999
11. Stable solid-phase Rh antigen
- Author
-
Marwan Yared, Kenneth J. Moise, and L. S. Rodkey
- Subjects
Cell Extracts ,Hemagglutination Inhibition Tests ,Buffers ,Epitopes ,Antigen ,medicine ,Animals ,Humans ,Fragmentation (cell biology) ,Immunoadsorption ,Immunoassay ,Rh-Hr Blood-Group System ,biology ,Chemistry ,Hematology ,Hemagglutination Tests ,Hydrogen-Ion Concentration ,Red blood cell ,medicine.anatomical_structure ,Biochemistry ,biology.protein ,Salts ,Rabbits ,Antibody ,Quantitative analysis (chemistry) ,Rh blood group system ,Plastics - Abstract
Numerous investigators have attempted to isolate the Rh antigens in a stable, immunologically reactive form since the discovery of the Rh system over 56 years ago. We report here a successful and reproducible approach to solubilizing and adsorbing the human Rh antigen(s) to a solid-phase matrix in an antigenically active form. Similar results were obtained with rabbit A/D/F red blood cell antigens. The antigen preparation was made by dissolution of the red blood cell membrane lipid followed by fragmentation of the residual cytoskeleton in an EDTA solution at low ionic strength. The antigenic activity of the soluble preparations was labile in standard buffers but was stable in zwitterionic buffers for extended periods of time. Further studies showed that the antigenic activity of these preparations was enhanced, as was their affinity for plastic surfaces, in the presence of acidic zwitterionic buffers. Adherence to plastic surfaces at low pH maintained antigenic reactivity and specificity for antibody was retained. The data show that this approach yields a stable form of antigenically active human Rh D antigen that could be used in a red blood cell-free assay for quantitative analysis of Rh D antibody and for Rh D antibody immunoadsorption and purification.
- Published
- 1998
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.